Alcabes, 1995, Injection drug use and human immunodeficiency virus infection, Clin. Infect. Dis., 20, 1467, 10.1093/clinids/20.6.1467
Amara, 2001, Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine, Science, 292, 69, 10.1126/science.1058915
Benveniste, 1996, Comparative interleukin (IL-2)/interferon IFN-gamma and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SICmac251 virus, Proc. Natl. Acad. Sci. U.S.A., 93, 3658, 10.1073/pnas.93.8.3658
Bond, 1998, Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction, Proc. Natl. Acad. Sci. U.S.A., 95, 9608, 10.1073/pnas.95.16.9608
Brancato, 1995, Survival and mortality in a cohort of heroin addicts in 1985–1994, Minerva Med., 86, 97
Carr, 1993, Immune alterations in chronic morphine-treated rhesus monkeys, Adv. Exp. Med. Biol., 335, 35, 10.1007/978-1-4615-2980-4_6
Carr, 1993, Immune alterations in morphine-treated rhesus monkeys, J. Pharmacol. Exp. Ther., 267, 9
CDC, 2002, Estimated numbers of diagnoses of HIV/AIDS, by year of diagnosis and selected characteristics of persons, 1999–2002, HIV/AIDS Surveill. Rep., 14, 10
Chuang, 1993, Increased replication of simian immunodeficiency virus in CEM x174 cells by morphine sulfate, Biochem. Biophys. Res. Commun., 195, 1165, 10.1006/bbrc.1993.2167
Chuang, 1993, Modulation of simian AIDS by opioids, Adv. Biosci., 86, 573
Clerici, 1994, The Th1–Th2 hypothesis of HIV infection: new insights, Immunol. Today, 15, 575, 10.1016/0167-5699(94)90220-8
Cole, 1997, Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity, J. Virol., 71, 5069, 10.1128/JVI.71.7.5069-5079.1997
Comar, 1997, Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection, J. Clin. Invest., 100, 893, 10.1172/JCI119605
Conant, 1998, Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia, Proc. Natl. Acad. Sci. U.S.A., 95, 3117, 10.1073/pnas.95.6.3117
Daniel, 1985, Isolation of T-cell tropic HTLV-III-like retrovirus from macaques, Science, 228, 1201, 10.1126/science.3159089
Donahoe, 2004, Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model, J. Neuroimmunol., 147, 28, 10.1016/j.jneuroim.2003.10.011
Donahoe, 1993, Consequences of opiate-dependency in a monkey model of AIDS, Adv. Exp. Med. Biol., 335, 21, 10.1007/978-1-4615-2980-4_4
Eisenstein, 2001, Effect of opioids on oral Salmonella infection and immune function, Adv. Exp. Med. Biol., 493, 169, 10.1007/0-306-47611-8_20
El Hage, 2005, Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat, Glia, 50, 91, 10.1002/glia.20148
Flaherty, 1997, Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus, J. Virol., 71, 5790, 10.1128/JVI.71.8.5790-5798.1997
Flores-Villanueva, 2003, Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development, J. Immunol., 170, 1925, 10.4049/jimmunol.170.4.1925
Fultz, 1986, Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys), Proc. Natl. Acad. Sci. U.S.A., 83, 5286, 10.1073/pnas.83.14.5286
Giavedoni, 2005, Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology, J. Immunol. Methods, 301, 89, 10.1016/j.jim.2005.03.015
Guo, 2002, Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor, J. Invest. Med., 50, 435, 10.2310/6650.2002.32503
Gurwell, 2001, Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro, Neuroscience, 102, 555, 10.1016/S0306-4522(00)00461-9
Hatsukari, 2006, Morphine modulates monocyte–macrophage conversion phase, Cell. Immunol., 10.1016/j.cellimm.2006.03.004
Hendel, 1999, New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS, J. Immunol., 162, 6942, 10.4049/jimmunol.162.11.6942
Hilburger, 1997, Morphine induces sepsis in mice, J. Infect. Dis., 176, 183, 10.1086/514021
Ho, 2003, Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes, J. Pharmacol. Exp. Ther., 307, 1158, 10.1124/jpet.103.056697
House, 2001, Chronic morphine potentiates the inflammatory response by disrupting interleukin-1beta modulation of the hypothalamic–pituitary–adrenal axis, J. Neuroimmunol., 118, 277, 10.1016/S0165-5728(01)00337-X
Igarashi, 1999, Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus, Proc. Natl. Acad. Sci. U.S.A., 96, 14049, 10.1073/pnas.96.24.14049
Imami, 2002, A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection, J. Virol., 76, 9011, 10.1128/JVI.76.18.9011-9023.2002
Joag, 1996, Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques, J. Virol., 70, 3189, 10.1128/JVI.70.5.3189-3197.1996
Karlsson, 1997, Characterization of molecularly cloned simian–human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys, J. Virol., 71, 4218, 10.1128/JVI.71.6.4218-4225.1997
Kaslow, 1989, No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. A report from the Multicenter AIDS Cohort Study, JAMA, 261, 3424, 10.1001/jama.1989.03420230078030
Kelder, 1998, Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia, Ann. Neurol., 44, 831, 10.1002/ana.410440521
Kim, 2006, Transforming growth factor-{beta}1 regulates macrophage migration via RhoA, Blood, 10.1182/blood-2005-10-009191
Kumar, 2000, Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses, Virology, 274, 149, 10.1006/viro.2000.0444
Kumar, 2001, Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency virus (SHIV(89.6)P), Virology, 279, 241, 10.1006/viro.2000.0695
Kumar, 2002, Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus, Virology, 301, 189, 10.1006/viro.2002.1544
Kumar, 2004, Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian–human immunodeficiency virus, J. Virol., 78, 11425, 10.1128/JVI.78.20.11425-11428.2004
Li, 2003, Morphine enhances HIV infection of neonatal macrophages, Pediatr. Res., 54, 282, 10.1203/01.PDR.0000074973.83826.4C
Luciw, 1995, Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV), Proc. Natl. Acad. Sci. U.S.A., 92, 7490, 10.1073/pnas.92.16.7490
MacFarlane, 2000, Morphine increases susceptibility to oral Salmonella typhimurium infection, J. Infect. Dis., 181, 1350, 10.1086/315403
Mankowski, 2004, Cerebrospinal fluid markers that predict SIV CNS disease, J. Neuroimmunol., 157, 66, 10.1016/j.jneuroim.2004.08.031
Margolick, 1992, Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection, JAMA, 267, 1631, 10.1001/jama.1992.03480120069035
Maslin, 2005, Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection, Curr. HIV Res., 3, 303, 10.2174/157016205774370401
McManus, 2000, Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation, Am. J. Pathol., 156, 1441, 10.1016/S0002-9440(10)65013-4
Metzger, 1993, Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up, J. Acquired Immune Defic. Syndr., 6, 1049
Miller, 2001, Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders, Mol. Psychiatry, 6, 50, 10.1038/sj.mp.4000809
Miller, 2004, A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression, Mol. Psychiatry, 9, 99, 10.1038/sj.mp.4001378
Montella, 1992, T-lymphocyte subsets in intravenous drug users with HIV-1 infection, JAMA, 268, 2516, 10.1001/jama.1992.03490180047019
Munoz, 1992, Prognostic indicators for development of AIDS among intravenous drug users, J. Acquired Immune Defic. Syndr., 5, 694
Nathanson, 1999, The role of nonhuman primates in the development of an AIDS vaccine, AIDS, 13, S113
Peterson, 1990, Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures, AIDS, 4, 869, 10.1097/00002030-199009000-00006
Peterson, 1991, Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta, J. Immunol., 146, 81, 10.4049/jimmunol.146.1.81
Peterson, 1992, Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures, J. Immunol., 149, 676, 10.4049/jimmunol.149.2.676
Peterson, 1993, Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection, Adv. Exp. Med. Biol., 335, 181, 10.1007/978-1-4615-2980-4_26
Peterson, 1994, Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells, J. Neuroimmunol., 50, 167, 10.1016/0165-5728(94)90043-4
Peterson, 1998, The opioid–cytokine connection, J. Neuroimmunol., 83, 63, 10.1016/S0165-5728(97)00222-1
Reimann, 1996, A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys, J. Virol., 70, 6922, 10.1128/JVI.70.10.6922-6928.1996
Reimann, 1996, An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys, J. Virol., 70, 3198, 10.1128/JVI.70.5.3198-3206.1996
Reimann, 1999, Viral burden and disease progression in rhesus monkeys infected with chimeric simian–human immunodeficiency viruses, Virology, 256, 15, 10.1006/viro.1999.9632
Robinson, 1990, A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin A, J. Immunol. Methods, 132, 63, 10.1016/0022-1759(90)90399-G
Ronald, 1994, Continued drug use and other cofactors for progression to AIDS among injecting drug users, AIDS, 8, 339, 10.1097/00002030-199403000-00007
Roth, 2002, Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes, J. Infect. Dis., 185, 701, 10.1086/339012
Roy, 2001, Morphine directs T cells toward T(H2) differentiation, Surgery, 130, 304, 10.1067/msy.2001.116033
Roy, 2004, Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet, J. Neuroimmunol., 147, 78, 10.1016/j.jneuroim.2003.10.016
Sanders, 1998, Chemokines and receptors in HIV encephalitis, AIDS, 12, 1021, 10.1097/00002030-199809000-00009
Sasseville, 1996, Induction of lymphocyte proliferation and severe gastrointestinal disease in macaques by a nef gene variant SIVmac239, Am. J. Pathol., 149, 163
Seizer, 2005, Different sources of “help” facilitate the antibody response to hepatitis D virus delta antigen, J. Mol. Med., 83, 225, 10.1007/s00109-004-0598-0
Selwyn, 1992, Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection, N. Engl. J. Med., 327, 1697, 10.1056/NEJM199212103272401
Sepkowitz, 1995, Tuberculosis in the AIDS era, Clin. Microbiol. Rev., 8, 180, 10.1128/CMR.8.2.180
Shattock, 1994, Phagocytosis of Mycobacterium tuberculosis modulates human immunodeficiency virus replication in human monocytic cells, J. Gen. Virol., 75, 849, 10.1099/0022-1317-75-4-849
Silverstein, 2000, Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time, J. Virol., 74, 10489, 10.1128/JVI.74.22.10489-10497.2000
Singhal, 1996, Morphine modulates migration of monocytes, Nephron., 73, 526, 10.1159/000189135
Stipp, 2000, Characterization of immune escape viruses from a macaque immunized with live-virus vaccine and challenged with pathogenic SHIVKU-1, AIDS Res. Hum. Retrovir., 16, 1573, 10.1089/088922200750006092
Suzuki, 2002, Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: induction of CC chemokine receptor 5 expression for virus entry, J. Infect. Dis., 185, 1826, 10.1086/340816
Tashkin, 2004, Evidence implicating cocaine as a possible risk factor for HIV infection, J. Neuroimmunol., 147, 26, 10.1016/j.jneuroim.2003.10.010
Wand, 2002, The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade, Neuropsychopharmacology, 26, 106, 10.1016/S0893-133X(01)00294-9
Wang, 2001, Multiple paths for activation of naive CD8+ T cells: CD4-independent help, J. Immunol., 167, 1283, 10.4049/jimmunol.167.3.1283
Wyand, 1999, Protection by live, attenuated simian immunodeficiency virus against heterologous challenge, J. Virol., 73, 8356, 10.1128/JVI.73.10.8356-8363.1999
Zink, 1997, Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV, Am. J. Pathol., 151, 793
Zink, 1998, SIV infection of macaques-modeling the progression to AIDS dementia, J. NeuroVirol., 4, 249, 10.3109/13550289809114526
Zink, 1999, High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis, J. Virol., 73, 10480, 10.1128/JVI.73.12.10480-10488.1999
Zink, 2001, Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis, J. Infect. Dis., 184, 1015, 10.1086/323478